Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A

Biochem Biophys Res Commun. 1994 Dec 30;205(3):1755-61. doi: 10.1006/bbrc.1994.2872.

Abstract

It has been recently reported that the 72 kDa proteolytic enzyme gelatinase A/type IV collagenase/matrix metalloproteinase 2 (MMP2) hydrolyzed the Lys 16-Leu 17 peptide bond of a synthetic decapeptide (YEVHHQKLVFF) representing the soluble A beta sequence of amino acid residues 10-20. Our aim was to test if this enzyme could also degrade the insoluble 40-42 residues long A beta peptides purified from Alzheimer Disease brain. Our results indicate that MMP2 hydrolyzes A beta 1-40 and A beta 1-42 peptides at Lys 16-Leu 17, at Leu 34-Met 35, and Met 35-Val 36 peptide bonds. These results suggest that MMP2 has the ability of degrading A beta of AD in vitro. If this hydrolysis also occurs in the brain's extracellular matrix, the enzymatic action of gelatinase a could prevent the generation of amyloidogenic A beta 1-40(42).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amino Acid Sequence
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / genetics
  • Amyloid beta-Peptides / metabolism*
  • Brain / metabolism*
  • Extracellular Matrix / metabolism
  • Gelatinases / metabolism*
  • Humans
  • Hydrolysis
  • In Vitro Techniques
  • Matrix Metalloproteinase 2
  • Metalloendopeptidases / metabolism*
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Solubility

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Recombinant Proteins
  • Gelatinases
  • Metalloendopeptidases
  • Matrix Metalloproteinase 2